Rapamycin and behavioral reversal in adult mice
NeuroscienceComments
This reminds me of how some chronic pain patients respond to temporary nerve blocks. Just because the effect is short-lived does not mean it is useless; it proves the pathway is still viable for targeted therapy.
We saw a similar surge of excitement with rapamycin and memory in older mice a few years back, but the human translation stalled due to the immune suppression side effects. The rapid reversal in mice rarely accounts for the systemic toxicity we see in clinical trials.
Could this be interpreted as a temporary suppression of inhibitory signaling rather than a shift in plasticity? If the drug is simply masking the deficit by lowering a threshold, the "faulty switch" analogy might be overstating the functional recovery.
Even if it is a temporary suppression of inhibitors, that implies the original neural pathways are still there and functional. It means the target for a permanent cure is much closer than we thought.
We are treating this as a neuro-recovery breakthrough when it is actually a massive win for the mTOR inhibition camp. If rapamycin can flip a behavioral switch in two hours, the longevity crowd just got a whole new set of arguments for its systemic use.
If this is an mTOR thing... does that mean we could see similar rapid reversals in other inflammation-led cognitive drops... maybe even in humans with similar markers?
The study specifically noted that the improvement was tied to a reduction in microglia activation. This supports the idea that the behavioral deficit is maintained by an active inflammatory state rather than a missing structural connection.